World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
102
Citations
77402
World Ranking
654
National Ranking
381

Medicine

D-Index
103
Citations
78186
World Ranking
7154
National Ranking
3759

Overview

Stephen A. Spector is affiliated with the University of California, San Diego in the United States. Their research focuses primarily on the fields of Medicine and Immunology and Microbiology, with substantive work in several subfields including Infectious Diseases, Virology, Immunology, Epidemiology, and Pediatrics, Perinatology and Child Health.

Their research topics encompass a range of areas centered on HIV and related health issues as well as mechanisms of disease at the cellular level. These topics include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • Autophagy in Disease and Therapy
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Pharmacological Effects and Toxicity Studies

Stephen A. Spector has contributed to multiple academic papers published in recognized venues. Some of their recent publications include:

  • "SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway," 2021, iScience
  • "Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children," 2020, American Journal of Respiratory and Critical Care Medicine
  • "Impact of alcohol exposure on neural development and network formation in human cortical organoids," 2022, Molecular Psychiatry
  • "Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial," 2023, Science Translational Medicine
  • "CD4 + T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy," 2020, mBio

Frequent coauthors in Stephen A. Spector's research include Ellen G. Chadwick, Grant R. Campbell, Elizabeth J. McFarland, Murli Purswani, and Megan Wilkins. These collaborations reflect sustained partnerships in their research endeavors.

The venues where they have published multiple works reflect a focus on infectious diseases and virology, with several papers appearing in:

  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • AIDS
  • Open Forum Infectious Diseases
  • Molecular Psychiatry
  • Journal of Virology

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

    Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant

    Rhoda S. Sperling;David E. Shapiro;Robert W. Coombs;John A. Todd

  • Lymphocyte subsets in healthy children from birth through 18 years of age : The pediatric AIDS clinical trials group P1009 study

    William T. Shearer;Howard M. Rosenblatt;Rebecca S. Gelman;Rebecca Oyomopito

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Identification of a candidate therapeutic autophagy-inducing peptide

    Sanae Shoji-Kawata;Rhea Sumpter;Matthew J Leveno;Grant R. Campbell;Grant R. Campbell

  • A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection

    Albert W. Wu;Haya R. Rubin;William C. Mathews;John E. Ware Jr.

  • Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

    D D Richman;D Havlir;J Corbeil;D Looney

  • Evidence for Early Central Nervous System Involvement in the Acquired Immunodeficiency Syndrome (AIDS) and Other Human Immunodeficiency Virus (HIV) Infections: Studies with Neuropsychologic Testing and Magnetic Resonance Imaging

    I Grant;J H Atkinson;J R Hesselink;C J Kennedy

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study.

    Atkinson Jh;Grant I;Kennedy Cj;Richman Dd

  • Muscle architecture and force-velocity characteristics of cat soleus and medial gastrocnemius: implications for motor control

    S. A. Spector;P. F. Gardiner;R. F. Zernicke;R. R. Roy

  • Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome

    P. Meier;J. A. Mccutchan;S. A. Bozzette;M. Clement

  • A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection.

    S. A. Bozzette;D. M. Finkelstein;S. A. Spector;P. Frame

  • Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

    Ellis Rj;Hsia K;Spector Sa;Nelson Ja

  • Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

    Richard J. Whitley;Gretchen Cloud;William Gruber;Gregory A. Storch

  • A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

    William G. Powderly;Dianne M. Finkelstein;Judith Feinberg;Peter Frame

  • Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

    Stephen A. Spector;George F. McKinley;Jacob P. Lalezari;Tobias Samo

  • High-Level Resistance of Cytomegalovirus to Ganciclovir Is Associated with Alterations in Both the UL97 and DNA Polymerase Genes

    Irene L. Smith;Julie M. Cherrington;Rhett E. Jiles;Michael D. Fuller

  • Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.

    W L Drew;D Ives;J P Lalezari;C Crumpacker

  • Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response

    Michael D. Hughes;Victoria A. Johnson;Martin S. Hirsch;James W. Bremer

  • Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

    Ian C. Marschner;Ann C. Collier;Robert W. Coombs;Richard T. D'Aquila

  • Panel on Clinical Practices for Treatment of HIV Infection

    Jean Anderson;A. Cornelius Baker;Samuel A. Bozzette;Charles Carpenter

Frequent Co-Authors

Douglas D. Richman
Douglas D. Richman University of California, San Diego
Samuel A. Bozzette
Samuel A. Bozzette University of California, San Diego
Ram Yogev
Ram Yogev Northwestern University
Deborah H. Spector
Deborah H. Spector University of California, San Diego
Patricia M. Flynn
Patricia M. Flynn St. Jude Children's Research Hospital
Igor Grant
Igor Grant University of California, San Diego
Sharon Nachman
Sharon Nachman Stony Brook Medicine
Lynne M. Mofenson
Lynne M. Mofenson Elizabeth Glaser Pediatric AIDS Foundation
George K. Siberry
George K. Siberry United States Department of State
Andrew Wiznia
Andrew Wiznia Albert Einstein College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, branching into related healthcare fields can expand career options. Many students explore nursing paths which offer practical experience with patient immune response and disease management. Programs such as lpn programs easy to get into provide accessible entry points for those starting their healthcare journey.

Advancing in nursing is also an option. For example, nurse practitioner programs with easy admission make it simpler to progress toward advanced clinical roles that frequently intersect with immunological care and treatment.

Specializing further, many graduates consider Mental Health Nursing, a field closely linked to immunology through the study of neuroimmunology and psychiatric disorders. Programs like the best psychiatric mental health nurse practitioner programs online support high-quality education combined with strong clinical placement opportunities.

Affordability is another key factor. For those looking to minimize costs, the cheapest psych np programs offer budget-friendly routes to becoming psychiatric nurse practitioners, allowing learners to invest wisely while pursuing essential licensure and specialization.

Best Scientists Citing Stephen A. Spector

Trending Scientists

Recently Published Articles